Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure

Fig. 1

Complement in HBV-ACLF group, CHB group and control group. a The concentrations of C1q were significantly lower in HBV-ACLF group than that in CHB group or in control group (P < 0.05). b There was no statistical significance of the plasma concentrations of MBL in all groups. c There was no statistical significance of the plasma concentrations of FB in all groups. d Complement C3 was significantly higher in the control group than that in the HBV-ACLF group (P < 0.05). e Complement C3a was significantly higher in the control group than that in the HBV-ACLF group (P < 0.05). f Complement C4 was significantly higher in the control group than that in the HBV-ACLF group (P < 0.05). g Complement C4a was significantly higher in the control group than that in the HBV-ACLF group (P < 0.05). h Complement C5b-9 was significantly higher in the control group than that in the HBV-ACLF group (P < 0.05). i The concentrations of C3 were significantly lower in the HBV-ACLF patients with pulmonary infection than that in the HBV-ACLF patients without pulmonary infection (P < 0.05)

Back to article page